2nd Quarter - Report
SIMS STRATEGIES, LLC for AMAG PHARMACEUTICAL
Firm
Client
Income
$80,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Pharmaceutical issues related to womens health product access.
Foreign entity interest: COVIS PHRMA GmbH, identified in a previous filing, holds the intellectual property underlying AMAG Pharmaceuticals work and would benefit from AMAGs success ensuring public access to its product.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD PRETTYMAN | Legislative Correspondent and Constituent Services Representative, Sen. Tom Carper (D-DE) |
| MICHAELA SIMS | Legislative Counsel, Sen. Ben Nelson (D-NE); Legislative Director and Counsel, Sen. Bob Kerrey (D-NE) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.